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Abstract: Aneuploidy, a deviation from a balanced genome by either gain or loss of chromosomes,
is generally associated with impaired fitness and developmental defects in eukaryotic organisms.
While the general physiological impact of aneuploidy remains largely elusive, many phenotypes
associated with aneuploidy link to a common theme of stress adaptation. Here, we review previously
identified mechanisms and observations related to aneuploidy, focusing on the highly diverse
eukaryotes, fungi. Fungi, which have conquered virtually all environments, including several hostile
ecological niches, exhibit widespread aneuploidy and employ it as an adaptive strategy under severe
stress. Gambling with the balance between genome plasticity and stability has its cost and in fact,
most aneuploidies have fitness defects. How can this fitness defect be reconciled with the prevalence
of aneuploidy in fungi? It is likely that the fitness cost of the extra chromosomes is outweighed by
the advantage they confer under life-threatening stresses. In fact, once the selective pressures are
withdrawn, aneuploidy is often lost and replaced by less drastic mutations that possibly incur a lower
fitness cost. We discuss representative examples across hostile environments, including medically
and industrially relevant cases, to highlight potential adaptive mechanisms in aneuploid yeast.
Keywords: aneuploidy; stress adaptation; genome plasticity; chromosome instability
1. Introduction
Aneuploidy, an unbalanced genomic state with gain or loss of chromosomes, has been observed
across eukaryotic organisms and often leads to severe fitness cost and developmental defects [1–5].
While an aneuploid genome encompasses thousands or millions of possible numerical combinations of
chromosomes during cell divisions, each aneuploid genome type may confer a unique phenotypic
profile [6], and thus, it is nearly impossible to approach the “genotype-to-phenotype” landscape
comprehensively. For instance, budding yeast Saccharomyces cerevisiae has 16 chromosomes in a haploid
genome; there can be, in theory, 65534 possible aneuploid karyotypes (216-2) when the chromosome copy
number variation is limited to only one or two copies. The numerous chromosome combinations and
the ongoing genome instability limit our ability to define the phenotypic characteristics of aneuploidy.
The earliest studies of the phenotypic consequences of aneuploidy were in the flowering plant, Datura,
where aneuploids, particularly those with lower basal ploidy levels, were severely defective [7,8].
Many human diseases, such as Down syndrome and cancer, are attributed to aneuploidy [9–13],
and paradoxically, the aneuploid state frequently exists in normal neuronal cells and hepatocytes in
mammals [14–17]. In eukaryotic microbes, aneuploidy enables rapid adaptation to environmental
challenges by conferring genomic and phenotypic variation [6,18–24]. In this review article, we will
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highlight the current perspective and the examples of aneuploidy providing fungal species survival
niches under various environmental conditions.
2. Cellular Impacts of Genome Aneuploidization
In the past two decades, extensive investigations in S. cerevisiae have revealed several stress
signatures in aneuploid cells [1,6,25–31]. A panel of disomic yeast strains were first analyzed by
Amon and colleagues, systematically showing proliferative defects resulting from cell cycle delays,
persistent DNA damage, elevated levels of reactive oxygen species and hyper-susceptibility to particular
reagents, such as cycloheximide and MG132 interfering with translation and the proteasome, in several
disomic aneuploidies (Figure 1) [1,26,28,29,32,33]. These phenotypes result from an overproduction of
proteins coded on aneuploid chromosomes, especially those proteins in multi-subunit complexes with
well-defined stoichiometry [34]. Indeed, gain of a specific chromosome alone, encoding dosage-sensitive
genes, causes lethality in yeast due to stoichiometric imbalance (e.g., copy number gain of TUB2 on
aneuploid chromosome VI) [35]. Further, many of these aneuploid strains exhibiting proteotoxic stress
are prone to Hsp104-associated protein aggregations while excess proteins overload the protein quality
control systems and titrate protein chaperons, causing the accumulations of damaged or unfolded
peptides [28]. A loss of function mutation in UBP6, encoding a deubiquitinating enzyme, improves the
proliferative rates of four tested disomic strains (gain of chromosome V, VIII, IX and XI). The impacts
of altered proteome in these disomic strains were attenuated in the absence of UBP6 function either
by enhanced degradation of excess proteins or by increased clearance of protein aggregates [1,25,28].
Additionally, another deubiquitinase enzyme UBP3, involved in vesicle transport, was identified in
a genome-wide screen as a gene which upon deletion impairs the fitness of several disomic strains
(gain of chromosome II, XI, XII, XIV, XV and XVI) [30]. Taken together, proteotoxic stress is observed in
many analyzed disomic strains (Figure 1), but not in all disomic strains or yeast with more complex
aneuploid stoichiometries. More transcriptomic analyses were performed in selected aneuploid strains,
and most disomic yeast (W303 laboratory strain background) exhibited a transcriptional profile similar
to the environmental stress response (ESR), a general expression signature triggered by diverse stresses
in yeast [36]. However, this transcriptional profile was not observed in all disomic yeast (F45 strain
background) [37], wild yeasts [38] or yeast populations generated by random aneuploidization [31].
In addition to the well-recognized proteotoxic stress in selected aneuploid strains from considerable
studies, a common physiological change associated with aneuploid cells harboring diverse aneuploid
karyotypes has been identified in a recent study from Li and colleagues [31]. Transcriptomic analyses
were performed from mixed aneuploid populations, including thousands of meiotic progeny of
triploid yeast, with random karyotypes, where the karyotype-specific expression is minimized.
By comparing the genomic expression pattern in aneuploid populations with those of cells under
diverse stress conditions, the aneuploidy-associated transcriptome resembling hypo-osmotic stress
responses was uncovered as a common biophysical signature in aneuploid cells irrespective of
their aneuploid karyotypes. This osmotic imbalance is a direct impact of the unbalanced proteome
caused by excessively produced proteins, especially unassembled protein subunits from complexes,
that increase intracellular osmolarity (Figure 1). Consequently, an increased intracellular turgor due
to water influx in aneuploid cells results in cell surface stress, opposing endocytic machineries and
further desensitizes the turnover of plasma membrane transporters in response to metabolic cues.
The aneuploid phenotypes under this hypo-osmotic stress state also renders a genetic dependence
on the ART-Rsp5 mediated endocytic pathway to modulate intracellular homeostasis [31]. The study,
for the first time, reveals a common signature in aneuploid cells with random karyotypes. Yet, it remains
elusive how the aneuploid state with its mostly negative effects, contributes to the high cell adaptability
to harsh environments.
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Figure 1. A brief overview of cellular impacts from genome aneuploidization. Aneuploidization may
occur when cells are under unfavorable conditions, leading to large-scale gene copy number variation.
An overproduction of proteins from genes on aneuploid chromosomes causes proteome imbalance, while
an excess flux of free protein subunits (e.g., red semicircles), which are not assembled into protein
complexes with well-defined stoichiometry (red + green semicircles), could perturb the proteostasis network.
The proteasome system could be overwhelmed due to the needs of degrading excess proteins (e.g., red
semicircles and purple triangles). Increased loads of protein aggregates (grey rectangles) can be detected
as a consequence of reduced Hsp90 folding capacity in aneuploidy. ROS levels are also increased, leading
to oxidative stress. In addition, these extra protein subunits increase intracellular osmolarity triggering
an influx of water (blue arrow), that leads to hypo-osmotic stress. As a result, an increased turgor pressure
causes membrane stress. At the level of transcription, genes from euploid chromosomes (blue and dark
blue bands), targeted by transcription factors encoded on aneuploid chromosomes (pink bands), could
also be overexpressed; in parallel, aneuploidy may change epigenetic landscape, such as post-translational
modifications (light orange flag on a gene labeled with green band), in a genome-wide manner to affect gene
expression (green bands). As aneuploidy is a direct outcome of genomic instability (GIN) or chromosomal
instability (CIN), it could drive further GIN and CIN from defective DNA damage repair and mitotic errors
and may exacerbate the existing defective phenotypes. On the other hand, mitotic stress from GIN and
CIN may continuously generate karyotype diversity in the cell population for adaptive phenotypes under
stressful conditions. Once the stress is withdrawn or a gene mutation with relatively minor fitness trade-off
occurs, cells may revert to the euploid state.
3. Aneuploid Fungi Are Widespread in Diverse Environments
Ploidy variation is widely observed in fungal species across wild, clinical and laboratory
environments [39]. Petrov and colleagues showed that, of 145 diploid S. cerevisiae MA lines (mutation
accumulation) evolving for an average of 2062 generations each, 31 sequenced strains were aneuploid (29 gain
and two loss of chromosome events), suggesting aneuploidy likely occurs frequently in an evolutionary time
scale [40]. Wild yeast isolates from Evolution Canyon, Israel, displayed tolerance to multiple environmental
stresses, including high multi-metal abundances, UV radiation and oxidative stress, and further phenotypic
analyses of selected adaptive phenotypes are associated with aneuploidy and other large-scale chromosomal
rearrangements [41–43]. For instance, natural isolates showing high tolerance to copper and cadmium
carried segmental aneuploid chromosomes, and the rearranged chromosomes frequently reverted back to
euploid when the stress was relaxed [43]. This phenotype of losing segmental aneuploid chromosomes
under a less selective environment suggests that aneuploidy drives adaptation but meanwhile leads to
fitness cost. Gasch and colleagues surveyed 47 non-laboratory yeast including 15 wild isolates (plant,
soil and insects), 19 industrial isolates (fermentation, beer, wine and bakery), 12 clinical isolates and one
undocumented isolate [38]. Nearly a third of sequenced strains were aneuploid (three in wild isolates,
eight in industrial isolates and three in clinical isolates), and these natural aneuploidies showed minimal
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fitness cost, in contrast to laboratory aneuploid strains [1,38]. As such, aneuploidy is well tolerated in
wild S. cerevisiae and can be leveraged to rapidly adapt to unexpected stresses in the wild. Yet, the cellular
mechanisms of how these stable aneuploid genomes cope with natural environmental stress remain unclear,
since the investigations in the laboratory cannot fully recapitulate their evolutionary history.
Clinical isolates of human pathogenic fungi, such as Candida and Cryptococcus species, have been
intensively studied in light of the tight relationship between large-scale genome instability and antifungal
resistance [44]. Copy number variations associated with phenotypes of antifungal resistance were first
detected in clinical Candida glabrata isolates, harboring aneuploid chromosomes [45–47]. A direct link between
aneuploidy and adaptive drug resistance was confirmed in another pathogenic fungus,Candida albicans, isolated
from bone marrow transplant (BMT) patients [18]. In this panel of clinical isolates, aneuploid isochromosome 5
(i5L) was frequently observed from aCGH microarray analyses, and additional experiments showed that gene
amplifications of ERG11 and TAC1 on the i5L chromosome drives resistance to the commonly used azole drug,
fluconazole [48]. Further investigations tracking the evolution of clinical fungal isolates in chronological order
found that drug resistance-associated mutations are likely fixed in the adapted population while aneuploidy
was mostly transient [49]. This suggests that aneuploidy provides a unique niche during the evolution of
drug resistance, mostly a rapid solution for coping with the antifungal stress in vivo. Experimental evolution,
in parallel, supports these observations by acquiring the same aneuploid chromosomes rendering fluconazole
resistance, and of note, i5L could appear in less than four generations, indicating aneuploidization drives rapid
adaptation to antifungal stress [50]. Moreover, karyotypic analyses in clinicalCandida auris, a known multidrug
resistant fungus, also showed ongoing, massive chromosomal rearrangements or possibly a transient aneuploid
state, with near-haploid genome content, supporting the idea that aneuploidy could be an intermediate status
promoting adaptation [51].Cryptococcus species also leverage aneuploidy or other large-scale genome instability
events to obtain growth advantage under antifungal stress. C. neoformans, by gaining additional chromosome
1 or 4, confers fluconazole resistance phenotypes [23,52,53]. Meanwhile, polyploid C. neoformans titan cells,
resistant to host stress, can produce aneuploid progeny when exposed to fluconazole, but generate haploid
progeny under an optimal growth condition, indicating a selective preference of aneuploid state for antifungal
adaptation [54]. S. cerevisiae, a widely used fungus in commercial products, may evolve under host stress and
become pathogenic, with increased virulence, to the host. More than a third of clinical S. cerevisiae strains were
identified as aneuploid (36% of 144 sequenced yeast strains, 132 from clinical isolates), while the other third
was polyploid (3N or 4N). The high ploidy variations in these isolates could be explained by the frequently
observed NDC80 mutation, an essential gene for chromosomal fidelity [55]. Therefore, aneuploidization
(or polyploidization) events in S. cerevisiae may drive phenotypic switch, from commensal to pathogenic in the
host environment. In contrast, specific aneuploid karyotype may also promote commensalism balanced by
a myriad of host stress including immune responses [56].
Experimental evolution has enabled the exploration of evolutionary trajectories with controllable
environmental parameters, such as limited or undesired nutrition resources, antifungal compounds, extreme
temperatures and those mimicking wild or host environments, to track how cells adapt to stress on
an evolutionary time-scale. Evidently, aneuploid yeast emerge rapidly from different adverse environments,
and specific aneuploid karyotypes drive adaptive phenotypes in the context of certain stress conditions
(Table 1) [6,24,57–72]. For example, laboratory haploid and diploid S. cerevisiae (S288c background) growing
in glucose-limited and phosphate-limited chemostats for over 200 generations, substantial aneuploidy was
detected in many adaptive diploids, exhibiting selective advantages, consistent with earlier observations
in a glucose-limited condition [59,73]. In another example, tetraploid, diploid and haploid cells were
passaged in a poor carbon source, raffinose, and aneuploid chromosome XIII was observed to confer
a significant fitness increase to tetraploid strains in raffinose, but not in glucose, while diploid and haploid
cells did not acquire aneuploidy during the experiments, echoing the specific, context-dependent nature
of aneuploidy [66]. Of note, when stress was applied gradually rather than abruptly, aneuploidy did not
emerge [62], reinforcing the idea that aneuploidy is more likely a high-stakes adaptive tactic rather than
a fine-tuned strategy. Taken together, aneuploidy enables broad and rapid traversing of the search space for
adaptive phenotypes by introducing drastic copy number changes in a significant fraction of the genome [74].
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Table 1. Examples of aneuploidy acquired under diverse stresses across different fungal species.








Clinical isolates Fluconazoleresistance V (+1) *
ERG11,




OPC VI (+1) Forche et al. (2019) [56]
Laboratory
strains
Cisplatin resistance V (−1), II (+1), II(+2)
Yang et al. (2013) [75], Yang et
al. (2019) [76]
Hydroxyurea
resistance II (+1) Yang et al. (2019) [76]
Suppressor of RGD1








Confirmed Ford et al. (2015) [49]
C. neoformans
Clinical isolates Fluconazoleheteroresistance I (+1), IV (+1)
ERG11,
AFR1
Sionov et al. (2010) [23], Sionov








Ngamskulrungroj et al. (2012)
[52]
F. oxysporum Plant pathogen Increasedpathogenecity XIV (+1) **
SIX1, SIX3,
ORX1 Ma et al. (2010) [78]
N. haematococca Plant pathogen Increasedpathogenicity CD (+1) ** PDA6 Miao et al. (1991) [79]
S. pastorianus Industrial lager
strains




Van den Borek et al. (2015) [80]
Increased diacetyl
synthesis X (+1), XII (+2) ILV5, ILV3 Van den Borek et al. (2015) [80]
S. cerevisiae
Clinical isolates Host survival variable acrossstrain phylogeny Zhu et al. (2016) [55]
Environmental
isolates
Copper tolerance II (+1), VII (+1), VIII(+1)
CUP1, CUP2,
SCO1, SCO2
Ezov et al. (2006) [41], Chang et
al. (2013) [43]
Freeze-thaw
tolerance XII (+1) AQY2 Hose et al. (2015) [38]
Industrial




oxidation VII (+1), XIII (+2)
ADH2,




yield XI (+1) Zhang et al. (2015) [83]
Laboratory
strains
4-NQO resistance IV (+1) ATR1 Pavelka et al. (2010) [6]
Benomyl resistance XII (−1) Chen et al. (2012) [61]
Copper tolerance II (+1), VIII (+1) CUP1, SCO1,SCO2 Gerstein et al. (2015) [65]
Ethanol tolerance III (+1), VIII (+1) Voordeckers et al. (2015) [68]
Ferulic acid
tolerance XIV (+1) Sato et al. (2014) [63]
Flocculation I (+1) FLO1 Hope et al. (2017) [70]
Fluconazole
resistance VIII (+1) ERG11 Chen et al. (2012) [61]
Galactose tolerance VIII (+1) GAL80 Sirr et al. (2015) [67]
Glucose-limited
growth
I (+1), III (+1), V
(+1) *, XIV (−1) Speculated Gresham et al. (2008) [59]
Nitrogen-limited
growth (glutamine) XI, XI (+1–+4) * GAP1 Lauer et al. (2018) [62]
Heat shock
tolerance III (+1) 17 genes Confirmed Yona et al. (2012) [62]
High pH tolerance V (+1) Confirmed Yona et al. (2012) [62]
Phosphate-limited
growth
IV (+1), VI (+1), X
(+1), XIII (+2), XVI
(+1)
Speculated Gresham et al. (2008) [59]
Raffinose growth XIII (+1) Selmecki et al. (2015) [66]
Radicicol resistance XV (+1) STL1, PDR5 Chen et al. (2012) [61]
Suppressors of
MEC1 deficiency IV (+1) RNR1 Gasch et al. (2001) [58]
Suppressors of
MYO1 deletion XIII (+1), XVI (+1)
RLM1,








VIII (−1) PRP8, UTP9,KOG1, SCH9 Millet et al. (2016) [69]
Tunicamycin
resistance XVI (−1), II (+1)
ALG7, PRE7,
YBR085C-A
Chen et al. (2012) [61],
Beaupere et al. (2018) [71]
Xylose utilization I (−1) Sato et al. (2014) [63]
S. paradoxus Environmentalisolates
Freeze-thaw
tolerance XII (+1) AQY2 Will et al. (2010) [84]
The fungal species, strain characteristics and selected phenotype are indicated along with the corresponding
aneuploid chromosomes. In cases where specific genes on aneuploid chromosomes were implicated in the
phenotype, the implicated genes are listed. If aneuploidy was confirmed to be transient, it is noted. (* —segmental
aneuploidy, ** —accessory chromosome).
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4. Gene Copy Number Variations on Aneuploid Chromosomes Drive Adaptive Phenotypes
A classic example of aneuploidy driving an adaptive phenotype, such as antifungal resistance,
with a detailed mechanistic explanation, is in C. albicans, characterized by Berman and colleagues
(Table 1) [18,48,50,85,86]. Clinical isolates acquire resistance to fluconazole by gaining aneuploid
chromosomes with extra copies of ERG11 encoding lanosterol-14-α-demethylase targeted by
fluconazole, and TAC1 encoding a transcriptional activator of drug eﬄux pumps CDR1 and CDR2 on
euploid chromosome 3. ERG11 copy number is positively correlated with the levels of fluconazole
resistance, while increased ERG11 mRNA expression was observed in 35% of fluconazole resistant
C. albicans [48,87]. In parallel, a hyperactive TAC1 allele driving high levels of CDR1 and CDR2
expression, was also found on isochromosome 5L with high copy numbers [48,85]. These two distinct
pathways can lead to fluconazole resistance on a similar level, and in these clinical isolates with gain
of chromosome 5L, they additively, yet independently, affect the adaptive phenotypes of fluconazole
resistance [48]. Meanwhile, the upregulated genes and pathways (targets of TAC1, including CDR1/2)
are on multiple chromosomes across the genome [88], indicating that phenotypic changes in aneuploidy
could be due to either direct or trans-acting effects from drastic gene copy variations on aneuploid
chromosomes. Moreover, gene copy variations from aneuploid chromosomes could allow a broad
“phenotypic space” during adaptive process and thereby afford the potential for the selected karyotype
in one environment to dictate adaptation in another environment. For instance, a single karyotype,
trisomic chromosome 2, can confer cross adaptation to multiple unrelated drugs, as in the case between
the treatments of anticancer drug hydroxyurea and antifungal drug caspofungin, in C. albicans [76].
Copy number gains ofRNR1 andRNR21 genes conferred the adaptation to hydroxyurea and meanwhile,
independent of the hydroxyurea-resistance pathways, increased survival on caspofungin was observed
in the presence of the same chromosome 2 gain by a Crz1-independent pathway. However, the gene
specific mechanism of trisomic chromosome 2 for adapting to caspofungin remains unknown.
Further investigations to understand how antifungal stress leads to aneuploidization in C. albicans
reveal that the presence of fluconazole impedes cell cycle progression and causes cytokinesis failure [89].
In a subpopulation of yeast exposed to fluconazole for 12 hours, DNA content increased with abnormal
cell morphology during cell division, and these cells later become intermediate polyploid “trimeras”.
Following subsequent unequal segregation with multiple spindles for 1-3 cell divisions, trimeras
could yield viable aneuploid progeny with complex karyotypes that remain unstable with ongoing
chromosome instability. The “trimera” state can be found from cells under various types of azole
exposures and was also observed in non-albicans species, such as C. glabrata and other CUG-clade
Candida species [89]. Complex aneuploid karyotypes can also be observed in C. glabrata, which carries
chimeric chromosomes associated with high tolerance of fluconazole concentration [47,90]. Gain of
small or chimeric chromosomes increases copy numbers of genes such as PDH1 (a paralog of CDR1
multidrug ABC transporter and an ortholog of PDR5 in S. cerevisiae), that are associated with antifungal
resistances. However, this mechanism of aneuploidization via perturbed cytokinesis is not universal
to fungal species, such as more distantly related fungi, S. cerevisiae [89] and C. neoformans [91].
A subsequent study showed that during fluconazole treatment, uninucleate haploid C. neoformans
produced aneuploid progeny through asymmetric budding processes as a primary mechanism of
aneuploid formation, while multinucleated cells were only detected in a low frequency [91,92].
The levels of fluconazole resistance were correlated with the gene dosage effects of ERG11 and AFR1,
encoding an ABC transporter on chromosome 1. While rare intermediate polyploid “trimera” was
observed, polyploid C. neoformans “titan cells”, can also acquire aneuploidy to gain advantageous
growth under fluconazole treatment [54]. Nevertheless, the possible mechanisms, such as the events
of endoduplication or mitotic error, yielding asymmetric aneuploid progeny resistant to azoles in
C. neoformans and S. cerevisiae remain largely undetermined. In addition, aneuploidy is observed as
an intermediate state when ploidy reduction happens during the parasexual cycle in C. albicans [93–96].
Tetraploid and aneuploid cells could return to a diploid or near diploid state via concerted chromosome
loss, concomitant with recombination events, such as loss of heterozygosity, that could reveal a number
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of recessive traits. As such, both aneuploid intermediates and their subsequent diploid progeny could
facilitate adaptive phenotypes through diverse genetic variations produced by parasex.
Another mechanism leading to copy number variations and aneuploidy is through massive
genomic rearrangements through repeat sequences, characterized by Selmecki and colleagues [97].
By identifying and analyzing long repeat sequences across the C. albicans genome in 33 clinical
and experimentally evolved isolates, long-range genomic rearrangements through these long repeat
sequences can form copy number variations, segmental aneuploidy and loss of heterozygosity as
a source of genome plasticity. Consistent with the above example of i5L formation, long inverted
repeat sequences within CEN4 (and CEN5 in i5L formation) can result in isochromosome 4R leading to
increased fluconazole resistance [97]. In contrast, laboratory S. cerevisiae often uses short inverted repeat
sequences generating copy number variations, including amplifications of segmental chromosomes,
to adapt to stresses [72,98].
There is ample evidence of the selective advantage conferred by the gene dosage-based mechanism
of aneuploidy from experimental evolution in the laboratory and analyses of natural isolates (Table 1).
Under copper-rich conditions, the majority of both evolvingS. cerevisiae exhibit aneuploidy of chromosomes II,
VII or VIII, that provide extra copies ofSCO1/2which functions in transport of copper to cytochrome c oxidase
in the mitochondrial inner membrane, CUP1, which encodes a metallothionein and CUP2, which activates
transcription of CUP1, respectively [41,43,65]. Studies employing nutrient-deprivation selections revealed
similar principles—specific chromosomes harboring genes that facilitate the uptake or metabolism of the
limiting factor are upregulated often through gene amplification [59,73]. Additionally, specific aneuploid
karyotypes confer adaptation to high temperature, pH and ER stresses by virtue of extra copies of few specific
genes on the aneuploid chromosomes [62,71]. For instance, Beaupere et al. [71] demonstrated that resistance
to tunicamycin-induced ER stress attributed to the gain of an extra copy chromosome II, could be narrowed
down to the combined effect of three genes involved in regulation of protein folding and degradation,
ALG7, PRE7 and YBR085C-A, that are a GlcNAc-1-P transferase involved in synthesis of oligosaccharide
precursor for N-linked protein glycosylation, a subunit of the 20S proteasome and an uncharacterized
protein speculated to be a UPR signaling factor, respectively.
In the few cases where the mechanism by which aneuploidy affects relevant traits of industrial
yeast strains were uncovered, gene dosage effects were prominent (Table 1). In wine yeast, an increased
copy number of chromosome VII, which carries the alcohol dehydrogenase genes ADH2 and ADH3
is correlated with increased capacity to oxidize ethanol during fermentation [82]. In lager brewing
strains of S. pastorianus, production of diacetyl, an unwanted byproduct that is removed at the end
of fermentation, was correlated with aneuploidy of chromosomes III, VIII, X, XII, and XIV [80].
These chromosomes harbor genes involved in valine biosynthesis, which generates the precursor for
diacetyl production. Similarly, in a triploid industrial S. cerevisiae strain, isolated from corn mash used
in a Chinese bioethanol factory, a clone possessing an extra copy of chromosome XI displayed improved
ethanol yield. Further experiments indicated that the altered expression activity of some genes involved
in ergosterol synthesis on the aneuploid chromosomes partly explained the improvement [83].
While there is limited understanding of the role of aneuploidy in plant pathogenic fungi,
some of these phytopathogens are known to possess multiple dispensable chromosomes called
accessory chromosomes that are known to harbor virulence loci [99]. In one such fungal species,
Fusarium oxysporum f.sp. lycopersici (Fol), a tomato pathogen, supernumerary chromosome 14 can be
transferred between strains, converting a non-pathogenic strain into a pathogen. Interestingly, genes
for key proteins secreted during the spread of Fol in the tomato xylem involved in virulence (Six1, Six3)
and the putative oxidoreductase gene, ORX1 are encoded on chromosome 14 [78]. Another pathogen
Nectria haematococca, possesses an accessory chromosome harboring the genePda6, a pisatin demethylase
that allows detoxification of pisatin, an antimicrobial compound produced by garden pea plants [79].
Recently, sequencing of the single-spore isolates of a vegetable pathogen Phytophthora capsica revealed
heterogeneous, drastic, and stable aneuploidy. This dynamic, extreme aneuploidy was speculated to
confer observed resistance to mefenoxam, a commonly used phytopathogenic toxin [100]. In contrast,
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in isolates of the sudden oak death pathogen Phytophthora ramorum, aneuploid isolates exhibited slower
growth and lower pathogenicity compared to wild-type isolates, reiterating the dichotomous nature of
aneuploidy in host-pathogen interactions [101].
Apart from changes at the single cell level, aneuploidy can confer changes in complex, multicellular
phenotypes like colony morphology. Aneuploidy in wild yeast strains is often associated with
morphological changes, including elongated pseudohyphal growth and filamentous colonies. Dudley
and colleagues demonstrated that the gain of a single chromosome in a strain of S. cerevisiae was
sufficient to switch colony morphology from the “fluffy” to the “smooth” state [21,37], and its
subsequent loss, to revert the strain back to the fluffy state. Reducing the copy number of DIG1,
a transcription factor present on the aneuploid chromosome and involved in the regulation of certain
mating type specific genes partially converted the smooth morphology of the disomic cells back to fluffy,
while mild overexpression of DIG1 in the euploid, reverted the morphology in the opposite direction.
However, the partial phenotypic switching indicates that other genes on the aneuploid chromosome
might also be involved. Other community phenotypes such as flocculation and sedimentation are
essential steps of cell aggregation during the brewing process and were positively correlated with copy
numbers of chromosomes which harbor flocculin genes LgFLO, FLO1, FLO5 and FLO10 in industrial
yeast strains [80].
In addition to the direct effects of altered gene copy numbers in a context dependent manner,
the phenotypic switch in aneuploid cells may also result from epigenetic changes. A disomic
yeast with gain of chromosome X as well as other complex aneuploid karyotypes can impair
epigenetically-controlled transcriptional silencing at the mating-type loci [102]. This silencing defect
could be due to the nuclear positioning of the silent chromatin and may involve at least four genes
working synergistically, but not necessary functionally related, indicating a regulatory mechanism,
indirect or beyond copy number variations, caused by aneuploidy. Lastly, since aneuploidization
creates possibly unlimited phenotypic traits for adaptation to life-threatening stresses, it is likely that
cells may evolve novel phenotypes that are subsequently selected to cope with stress, rather than using
existing stress response pathways. For instance, Rancati et al. demonstrated that in the absence of
an essential gene MYO1 which is required for cytokinesis, rare ∆myo1 survivors with restored cell
division emerged via acquiring specific aneuploid stoichiometries [60]. This violation of supposed
‘essentiality’ was not recovered by restoring the original cytokinesis machinery when MYO1 was
reintroduced, but instead involved genes from seemingly unassociated pathways—a transcription
factor, RLM1 and a kinase, MKK1, both involved in maintaining cell wall integrity. This suggests that
apart from gene dosage based adaptive phenotypes, aneuploidy could potentially be a springboard for
neofunctionalization. However, how cells remodel the cell wall to cope with the changes in cytokinesis
during aneuploidization remains unclear. Furthermore, Rancati and colleagues found that 9% of the
conventionally defined “essential” genes could be overcome through adaptive evolution and ploidy
variations, including aneuploidy, reinforcing that it is a prevalent adaptive strategy [103].
5. Future Perspective
The balance between genome plasticity and stability is fine tuned to ensure cells survive and
propagate in a fluctuating or an unpredictable environment, such as in the wild or a host. Cells often
leverage aneuploidization, as a rapid and reversible strategy, to cope with diverse stress conditions.
In this review, we have provided representative examples and potential mechanisms to highlight
how aneuploidy contributes to fungal cell adaptation under various stress conditions. In addition to
gene copy variations, aneuploidy itself, even within the same karyotype, may display non-genetic
heterogeneity in response to environmental perturbations [104]. Thus, when mitotic error occurs,
random aneuploid karyotypes could provide the cell population numerous phenotypic traits, including
detrimental or beneficial individuals, to ensure the survival of progeny even in the most taxing
environments. Remarkably, this “gambling” strategy is not leveraged when the stress is applied
gradually rather than abruptly, and cells often revert to euploid once the stress is relieved or when
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a beneficial mutation emerges, as evident in both laboratory yeast and clinical isolates [43,49,62].
The detailed mechanisms of adaptive evolution driven by aneuploidy are elusive, and it remains to
be seen whether there is a molecular mechanism allowing cells to sense aneuploidization. How do
aneuploid cells under stress mitigate negative effects from hundreds of gene copy number variations
if only few contribute to the adaptive phenotypes? At the molecular level, questions on how stress
conditions lead to chromosome instability (CIN) also remain largely unanswered, although CIN genes
have been intensively investigated by many research groups [105–111].
Importantly, antifungal resistance is a rapidly emerging problem, and one of the contributing
mechanisms is genome instability, including many chromosomal-scale events. Strategies to effectively target
aneuploid fungi are becoming an obvious need in medicine. As such, genetic screens were performed to
identify a “magic bullet” targeting aneuploidy in different laboratory conditions [31,112,113]. While the
impact of aneuploidization is genome-wide, and it affords a high degree of genetic variation, it is difficult
to eliminate aneuploid fungi and to avoid antifungal adaptations. However, a proof-of-principle screen
demonstrated that cells are steered towards specific aneuploid karyotype under certain antifungal stress,
and a subsequent chemical screen that was performed eliminated the homogenized aneuploid population,
known as a strategy of “evolutionary trap” [114]. In parallel, a biophysical signature, hypo-osmotic stress
state, was reported recently as a phenotypic commonality in aneuploid yeast populations with random
karyotypes, that could be the Achilles’ heel of aneuploidy [31]. The work, along with other efforts in the field
may provide clinically useful insights in the foreseeable future. Yet, these studies also raise more questions
of cellular evolution during the adaptive process, particularly with regard to the ultimate goal of blocking
aneuploidy-driven antifungal adaptation. For instance, is there an absolute essentiality of cellular functions
in aneuploid cells given that we never observed a lethal phenotype through gene deletion screens in
aneuploid cells? Taken together, it is clear that while aneuploidy is a widespread and common phenomenon
across different fungal species and other eukaryotes, more in-depth investigations are required to understand
its fundamental biology and bring us closer towards solving the clinical problems in aneuploid diseases.
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